ソフィア・ジェネティクス
SOPHiA GENETICS S.A.
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.30 | $23M | -$10M |
| 2026 Q1 | -0.27 | $22M | -$17M |
| 2025 Q4 | -0.28 | $22M | -$9M |
| 2025 Q3 | -0.30 | $19M | -$9M |
| 2025 Q2 | -0.33 | $18M | -$10M |
| 2025 Q1 | -0.26 | $18M | -$12M |
| 2024 Q4 |
| -0.23 |
| $18M |
| -$13M |
| 2024 Q3 | -0.28 | $16M | -$9M |